This inventor holds 1 USPTO granted patent. Top assignees: Acornmed Biotechnology Co., Ltd. Beijing, Acornmed Medical Instrument Co., Ltd. Tianjin China. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1 
1 out of 1 Years Active: 2026
Title: Yafeng Zhang: Innovator in Urothelial Carcinoma Detection
Introduction
Yafeng Zhang is a prominent inventor based in Beijing, China. He has made significant contributions to the field of medical technology, particularly in the detection of urothelial carcinoma. His innovative approach combines advanced genetic features to enhance diagnostic accuracy.
Latest Patents
Yafeng Zhang holds a patent for a "Method and device for urothelial carcinoma detection." This patent outlines a system that utilizes copy number variation (CNV) features and single nucleotide variation (SNV) features to detect urothelial carcinoma effectively. The invention aims to improve early detection and treatment outcomes for patients.
Career Highlights
Throughout his career, Yafeng Zhang has worked with notable companies in the biotechnology sector. He has been associated with Acornmed Biotechnology Co., Ltd. in Beijing and Acornmed Medical Instrument Co., Ltd. in Tianjin, China. His work in these organizations has contributed to advancements in medical instrumentation and diagnostics.
Collaborations
Yafeng Zhang has collaborated with several professionals in his field, including Shanbo Cao and Libin Chen. These partnerships have fostered innovation and development in medical technologies.
Conclusion
Yafeng Zhang's contributions to urothelial carcinoma detection exemplify the impact of innovative thinking in medical technology. His work continues to influence the field and improve patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile